Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Cited In for PubMed (Select 8351519)

1.

Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.

Liu X, Jiang T, Piao C, Li X, Guo J, Zheng S, Zhang X, Cai T, Du J.

Sci Rep. 2015 Jun 19;5:11411. doi: 10.1038/srep11411.

2.

Crystal structure of the magnetobacterial protein MtxA C-terminal domain reveals a new sequence-structure relationship.

Davidov G, Müller FD, Baumgartner J, Bitton R, Faivre D, Schüler D, Zarivach R.

Front Mol Biosci. 2015 May 21;2:25. doi: 10.3389/fmolb.2015.00025. eCollection 2015.

3.

AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures.

Zambrano R, Jamroz M, Szczasiuk A, Pujols J, Kmiecik S, Ventura S.

Nucleic Acids Res. 2015 Jul 1;43(W1):W306-13. doi: 10.1093/nar/gkv359. Epub 2015 Apr 16.

4.

Genetic Modifiers for Neuromuscular Diseases.

Lamar KM, McNally EM.

J Neuromuscul Dis. 2014;1(1):3-13.

5.

Antisense therapy in neurology.

Lee JJ, Yokota T.

J Pers Med. 2013 Aug 2;3(3):144-76. doi: 10.3390/jpm3030144. Review.

6.

Aggregation propensities of superoxide dismutase G93 hotspot mutants mirror ALS clinical phenotypes.

Pratt AJ, Shin DS, Merz GE, Rambo RP, Lancaster WA, Dyer KN, Borbat PP, Poole FL 2nd, Adams MW, Freed JH, Crane BR, Tainer JA, Getzoff ED.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4568-76. doi: 10.1073/pnas.1308531111. Epub 2014 Oct 14.

7.

Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS.

Bourassa MW, Brown HH, Borchelt DR, Vogt S, Miller LM.

Front Aging Neurosci. 2014 Jun 16;6:110. doi: 10.3389/fnagi.2014.00110. eCollection 2014.

8.

Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.

Ayers JI, Xu G, Pletnikova O, Troncoso JC, Hart PJ, Borchelt DR.

Acta Neuropathol Commun. 2014 May 14;2:55. doi: 10.1186/2051-5960-2-55.

9.

Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.

Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, Blackbourn LW 4th, Huang CL, Errigo A, Yin Y, Lu J, Ayala M, Zhang SC.

Cell Stem Cell. 2014 Jun 5;14(6):796-809. doi: 10.1016/j.stem.2014.02.004. Epub 2014 Apr 3.

10.

Insights into SOD1-linked amyotrophic lateral sclerosis from NMR studies of Ni(2+)- and other metal-ion-substituted wild-type copper-zinc superoxide dismutases.

Ming LJ, Valentine JS.

J Biol Inorg Chem. 2014 Jun;19(4-5):647-57. doi: 10.1007/s00775-014-1126-5. Epub 2014 Apr 2.

11.

Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy.

Mesnard NA, Haulcomb MM, Tanzer L, Sanders VM, Jones KJ.

J Neurodegener Regen. 2013 Fall;4(1):21-25.

12.

Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell.

Polling S, Mok YF, Ramdzan YM, Turner BJ, Yerbury JJ, Hill AF, Hatters DM.

J Biol Chem. 2014 Mar 7;289(10):6669-80. doi: 10.1074/jbc.M113.520189. Epub 2014 Jan 14.

13.

Structural and functional analysis of human SOD1 in amyotrophic lateral sclerosis.

Moreira LG, Pereira LC, Drummond PR, De Mesquita JF.

PLoS One. 2013 Dec 2;8(12):e81979. doi: 10.1371/journal.pone.0081979. eCollection 2013.

14.

Relationships between tongue motility, grip force, and survival in SOD1-G93A rats.

Smittkamp SE, Spalding HN, Brown JW, Yeh HW, Stanford JA.

Physiol Behav. 2014 Feb 10;125:17-20. doi: 10.1016/j.physbeh.2013.11.010. Epub 2013 Nov 27.

15.

Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide.

Bennett CL, Chen Y, Vignali M, Lo RS, Mason AG, Unal A, Huq Saifee NP, Fields S, La Spada AR.

PLoS One. 2013 Nov 11;8(11):e78837. doi: 10.1371/journal.pone.0078837. eCollection 2013.

16.

Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.

Wang X, Blanchard J, Grundke-Iqbal I, Wegiel J, Deng HX, Siddique T, Iqbal K.

Acta Neuropathol. 2014 Feb;127(2):243-56. doi: 10.1007/s00401-013-1175-9. Epub 2013 Oct 18.

17.

Structural consequences of cysteinylation of Cu/Zn-superoxide dismutase.

Auclair JR, Brodkin HR, D'Aquino JA, Petsko GA, Ringe D, Agar JN.

Biochemistry. 2013 Sep 10;52(36):6145-50. doi: 10.1021/bi400613h. Epub 2013 Aug 26.

18.

Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Pandya RS, Zhu H, Li W, Bowser R, Friedlander RM, Wang X.

Cell Mol Life Sci. 2013 Dec;70(24):4729-45. doi: 10.1007/s00018-013-1415-0. Epub 2013 Jul 18. Review.

19.

The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type.

Richardson K, Allen SP, Mortiboys H, Grierson AJ, Wharton SB, Ince PG, Shaw PJ, Heath PR.

PLoS One. 2013 Jun 28;8(6):e68256. doi: 10.1371/journal.pone.0068256. Print 2013.

20.

Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats.

Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, Li F, Zhou H, Xia XG.

EMBO J. 2013 Jul 3;32(13):1917-26. doi: 10.1038/emboj.2013.122. Epub 2013 May 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk